Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
To keep drug prices high, pharma has been piling up the patents
The cost of healthcare in general is a debilitating, pre-existing condition for Americans. But the high prices of prescription drugs usually stand out as a pain point. While there are many insidious reasons why Americans pay more—often far…
Lilly CEO Eyes Bigger Deals in Hunt for Pharma's 'White Spaces'
Investors should expect Eli Lilly & Co. to strike slightly larger deals, along the lines of its $7.8 billion acquisition of Centessa Pharmaceuticals Plc, as it casts a wide net for assets in the “white spaces” of science, Chief…
Novo and Hengrui Pharma enter exclusive license agreement for once-weekly oral GLP-1/GIP dual receptor agonist HRS-1596
HRS-1596 is a phase 1-ready GLP-1/GIP dual receptor agonist for once-weekly oral dosing Total potential deal value is up to 2.6 billion US dollars, including 300 million dollars upfront, as well as potential sales royalties Bagsværd, Denmark…
India Gets US Pharma Tariff Exemption, But Which Drugs Still Face Trump's 100% Duty?
Washington: The United States has exempted select pharmaceutical products and related components originating from India and 19 other partner jurisdictions from import duties, even as Washington moves ahead with a 100 per cent tariff on specified…
Why rare-disease drugs could become India's next pharma frontier
Each rare disease affects very few people. However, there are around 8,000 rare diseases, and they cumulatively affect hundreds of millions of people. In India, 1,004 rare genetic disorders have been reported so far. It used to be that because the…
Sun Pharma inks pact with LIB Therapeutics to sell LDL-C drug
Sun Pharmaceutical Industries and LIB Therapeutics Inc on Monday announced an exclusive licensing agreement granting the Indian drug maker rights to commercialise and manufacture lerodalcibep worldwide, excluding the U.S. and China. The agreement…
Roche Holding AG (RHHBY) Discusses Pharma Strategy, R&D Excellence, AI in Drug Development, and Pipeline Updates Across Key Therapeutic Areas Transcript
Roche Holding AG (RHHBY) Discusses Pharma Strategy, R&D Excellence, AI in Drug Development, and Pipeline Updates Across Key Therapeutic Areas September 28, 2026 4:30 AM EDT Bruno Eschli - Head of Investor Relations Teresa Graham - Chief Executive…
Surat-based Anupam Rasayan completes ₹1,750-cr acquisition of 48.2% in Bliss GVS Pharma
Surat-based Anupam Rasayan India has completed the acquisition of a 48.2 per cent controlling stake in Bliss GVS Pharma for a total acquisition outlay of ₹1,750 crore, marking its third strategic inorganic transaction, as the Surat-based…
Natco Pharma raises eGenesis investment to $16.70 million
Natco Pharma Ltd on Monday said it has decided to increase its proposed investment in US-based biotechnology firm eGenesis Inc to USD 16.70 million (around Rs 139 crore) from the previously disclosed amount of USD 14 million. Under the revised…
Anupam Rasayan completes purchase of 48.2 pc stake in Bliss GVS Pharma for ₹1,750 cr
Specialty chemicals maker Anupam Rasayan India on Tuesday said it has completed the acquisition of a 48.2 per cent controlling stake in Bliss GVS Pharma for ₹1,750 crore, marking its push into finished dosage formulations. It is Anupam…
Democrat Abdul El-Sayed courts RFK Jr.'s MAHA voters with new health policy platform
Washington — Michigan Democratic Senate candidate Abdul El-Sayed is making a play for Robert F. Kennedy Jr.'s 'Make America Healthy Again' supporters with the release Tuesday of a new health policy platform. 'I think we have an opportunity…
AstraZeneca to Invest $2 Billion in Summit Therapeutics, Collaborate on Cancer Drugs
is investing $2 billion into Summit Therapeutics as part of an expanded partnership between the two companies. Summit said Monday that AstraZeneca will buy $2 billion of convertible preferred shares, representing a common stock price of $18.36 a…
NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Up 5.8% - What's Next?
Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) rose 5.8% on Monday. The stock traded as high as $23.74 and last traded at $23.8850. Approximately 708,318 shares were traded during trading, a decline of 37% from the…
Nuvectis Pharma, Inc. (NASDAQ:NVCT) Stock Has Consensus Target Price of $36.25 According to Brokerages
Shares of Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report) have been given a consensus recommendation of 'Moderate Buy' by the five research firms that are presently covering the company, MarketBeat Ratings reports. One investment analyst has…
Stock markets tumble in early trade
Equity benchmark indices Sensex and Nifty tumbled in early trade on Tuesday as elevated crude oil prices due to uncertainty over the West Asia situation and foreign fund outflows weighed on investors' sentiment. The 30-share BSE Sensex dropped 503…
Receive a Daily briefing on Pharma Industry News
Get Started